Sfoglia per AUTORE
LOBO C
Collezione AOU San Luigi di Orbassano
Items : 2
ENESTnd 5-year (y) update: Long-term outcomes of patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) treated with frontline nilotinib (NIL) versus imatinib (IM) in Journal of Clinical Oncology
2014
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Larson RA; Kim D-W; Jootar S; Pasquini R; Clark RE; Lobo C; Goldberg SL; Shibayama H; Hochhaus A; Saglio G; Kantarjian HM; Kemp C; Deng W; Menssen HD; Hughes TP;
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia. in The New England journal of medicine / N Engl J Med. 2010 Jun 17;362(24):2251-9. doi: 10.1056/NEJMoa0912614. Epub 2010 Jun 5.
2010
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Saglio G; Kim DW; Issaragrisil S; le Coutre P; Etienne G; Lobo C; Pasquini R; Clark RE; Hochhaus A; Hughes TP; Gallagher N; Hoenekopp A; Dong M; Haque A; Larson RA; Kantarjian HM;